The US Food and Drug Administration only asked Botanix for a small change – but it led to a 25 per cent drop for the ASX health stock. The FDA has requested changes to the product use instructions – a ...
The FDA has requested changes to the product use instructions – a paper inserted in the product carton that tells the patient how to safely and effectively use it. However, no clinical efficacy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback